(Q45740410)

15 December 2017

Epstein-Barr virus in gastric carcinomas with lymphoid stroma (English)

1 reference

15 December 2017

0 references

Chang MS

1

1 reference

15 December 2017

Kim WH

series ordinal

2

1 reference

15 December 2017

Kim CW

series ordinal

3

1 reference

15 December 2017

Kim YI

series ordinal

4

1 reference

15 December 2017

1 October 2000

1 reference

15 December 2017

1 reference

15 December 2017

37

1 reference

15 December 2017

4

1 reference

15 December 2017

309-315

1 reference

Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis

15 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

p53: oncogene or anti-oncogene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.01014.X

10.1046/J.1365-2559.2000.01014.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference